A detailed history of Charles Schwab Investment Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,465,690 shares of TECH stock, worth $90.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,465,690
Previous 1,414,003 3.66%
Holding current value
$90.5 Million
Previous $113 Million 6.57%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$66.37 - $78.17 $3.43 Million - $4.04 Million
51,687 Added 3.66%
1,465,690 $106 Million
Q3 2024

Nov 12, 2024

SELL
$70.96 - $82.35 $6.31 Million - $7.32 Million
-88,911 Reduced 5.92%
1,414,003 $113 Million
Q2 2024

Aug 12, 2024

BUY
$62.12 - $84.15 $2.14 Million - $2.9 Million
34,467 Added 2.35%
1,502,914 $108 Million
Q1 2024

May 08, 2024

BUY
$65.98 - $77.09 $1.88 Million - $2.2 Million
28,528 Added 1.98%
1,468,447 $103 Million
Q4 2023

Feb 06, 2024

BUY
$52.83 - $78.22 $1.48 Million - $2.2 Million
28,095 Added 1.99%
1,439,919 $111 Million
Q3 2023

Nov 08, 2023

SELL
$67.52 - $89.42 $360,556 - $477,502
-5,340 Reduced 0.38%
1,411,824 $96.1 Million
Q2 2023

Aug 09, 2023

BUY
$73.76 - $85.98 $628,951 - $733,151
8,527 Added 0.61%
1,417,164 $116 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $714,051 - $863,601
9,970 Added 0.71%
1,408,637 $105 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $85.5 Million - $374 Million
1,060,271 Added 313.32%
1,398,667 $116 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $2.35 Million - $3.26 Million
8,308 Added 2.52%
338,396 $96.1 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $3.7 Million - $5.16 Million
11,472 Added 3.6%
330,088 $114 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $3.81 Million - $5.25 Million
10,765 Added 3.5%
318,616 $138 Million
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $4.62 Million - $5.32 Million
10,136 Added 3.4%
307,851 $159 Million
Q3 2021

Nov 16, 2021

BUY
$444.87 - $538.88 $33 Million - $39.9 Million
74,134 Added 33.16%
297,715 $144 Million
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $1.96 Million - $2.27 Million
5,048 Added 2.31%
223,581 $101 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $4.26 Million - $5.56 Million
-13,538 Reduced 5.83%
218,533 $83.5 Million
Q4 2020

Feb 16, 2021

BUY
$246.9 - $321.87 $976,489 - $1.27 Million
3,955 Added 1.73%
232,071 $73.7 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $583,336 - $710,795
2,512 Added 1.11%
228,116 $56.5 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $3.79 Million - $5.72 Million
-20,462 Reduced 8.32%
225,604 $59.6 Million
Q1 2020

May 15, 2020

BUY
$161.17 - $221.51 $405,342 - $557,097
2,515 Added 1.03%
246,066 $46.7 Million
Q4 2019

Feb 07, 2020

BUY
$189.68 - $222.09 $2.22 Million - $2.6 Million
11,717 Added 5.05%
243,551 $53.5 Million
Q3 2019

Nov 08, 2019

BUY
$183.56 - $216.72 $2.86 Million - $3.37 Million
15,571 Added 7.2%
231,834 $45.4 Million
Q2 2019

Aug 09, 2019

BUY
$188.72 - $215.43 $1.18 Million - $1.35 Million
6,269 Added 2.99%
216,263 $45.1 Million
Q1 2019

May 14, 2019

BUY
$136.09 - $200.44 $689,704 - $1.02 Million
5,068 Added 2.47%
209,994 $41.7 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $117,483 - $180,363
885 Added 0.43%
204,926 $29.7 Million
Q3 2018

Nov 13, 2018

SELL
$147.44 - $204.11 $10.3 Million - $14.2 Million
-69,667 Reduced 25.45%
204,041 $41.6 Million
Q2 2018

Aug 08, 2018

BUY
$144.9 - $165.58 $3.81 Million - $4.36 Million
26,305 Added 10.63%
273,708 $40.5 Million
Q1 2018

May 07, 2018

BUY
$131.46 - $151.04 $5.38 Million - $6.18 Million
40,893 Added 19.8%
247,403 $37.4 Million
Q4 2017

Jan 17, 2018

BUY
$121.17 - $134.75 $1.13 Million - $1.26 Million
9,326 Added 4.73%
206,510 $26.8 Million
Q3 2017

Nov 13, 2017

BUY
$113.59 - $123.78 $22.4 Million - $24.4 Million
197,184
197,184 $23.8 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.42B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.